Toll Free Number: 1800-200-4444

An International Marketplace with the Largest Online Business Directory of Buyers & Sellers.
 

Gan & Lee Pharmaceutical Ltd.


Company Profile
About us:
Our company, Gan & Lee Pharmaceutical Co. Ltd., is the only Bio-Pharmacological enterprise that focuses on biosynthetic human insulin in China since 1994. The research, development and manufacture of its biosynthetic human insulin and analogs are all keeping lead in the world.

About the product line:
Our company possesses the complete product line including biosynthetic human insulin and analog. Our strongly recommended products are: Insulin Glargine and Insulin Lispro, which are manufactured by the third generational production process of recombinant insulin.

About the scale:
Our company has a modern insulin plant in the world in Beijing. Annual capacity is up to 100 million cartridges or 1000kg API.

About our partners:
We have been exported to many countries and have many excellent cooperative partners. LG LIFE SCIENCE is one of them and established a long term relationship since 2006 and has kept the win-win situation.

About our products:
Our product, recombinant insulin glargine, named Basalin, is the only true basal insulin analog, offers patients once-daily administration and peakless action, reduces the risk of hyperglycemia, and improves metabolic control.

About Why you choose us
1.Gan&Lee is one of the very few companies that are capable of producing the Recombinant Insulin Glargine in the whole world.
2.Our production standard is higher than EP and USP.
3.The purity of products is up to 99.66%, higher than average value, 99.34%.
4.We have achieved PCT patent from America and Russia and many other countries. It is welcomed in the world wide.
5.Competitive price compare to the congeneric insulin, can enhance your competition.
6.Product advantages:
Constant and prolonging action. Basalin has been proven to lower basal glucose levels for a full 24 hours.
Efficient and easy to reach the target. Once-daily administration and peakless action.
Safe and reliable to lower glucose level. Reduces the risk of hyperglycemia dramatically.

Business Type : Manufacturer
Year Established : 1998
Main Markets : Asia, Africa, Australia, East Europe, West Europe, Middle East, North America, South America
Annual Sales : US$50 Million - US$100 Million
Total Employees : 501 - 1000 People
Total Professionals : 51 - 100 People

Products
Our product, recombinant insulin glargine, named Baseline, is the only true basal insulin analog, offers patients once-daily administration and peak
more details...

Prandilin®

Prandilin® is the ideal prandial insulin. It acts rapidly and reduces postprandial BG with an onset time of 15min. So it is
more details...


Contact Us
Du
Room 1805, Building C, Oriental Media Center, No. 4 Guanghua Road, Chaoyang District, Beijing, China
Beijing  
Beijing
China
Phone: 86-010-85597868
Fax: 86-010-85597851